Free Trial

New York State Common Retirement Fund Has $145.83 Million Position in CME Group Inc. (NASDAQ:CME)

CME Group logo with Finance background

New York State Common Retirement Fund decreased its holdings in CME Group Inc. (NASDAQ:CME - Free Report) by 10.7% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 549,691 shares of the financial services provider's stock after selling 65,550 shares during the quarter. New York State Common Retirement Fund owned 0.15% of CME Group worth $145,828,000 as of its most recent filing with the SEC.

A number of other hedge funds also recently made changes to their positions in CME. Bank Pictet & Cie Europe AG grew its holdings in shares of CME Group by 29.0% in the 4th quarter. Bank Pictet & Cie Europe AG now owns 86,941 shares of the financial services provider's stock worth $20,190,000 after purchasing an additional 19,533 shares during the last quarter. Proficio Capital Partners LLC acquired a new stake in CME Group in the 4th quarter valued at about $268,000. Sequoia Financial Advisors LLC increased its position in CME Group by 9.2% in the 4th quarter. Sequoia Financial Advisors LLC now owns 9,996 shares of the financial services provider's stock valued at $2,321,000 after acquiring an additional 845 shares in the last quarter. EverSource Wealth Advisors LLC increased its position in CME Group by 47.6% in the 4th quarter. EverSource Wealth Advisors LLC now owns 1,039 shares of the financial services provider's stock valued at $241,000 after acquiring an additional 335 shares in the last quarter. Finally, Great Lakes Advisors LLC increased its position in CME Group by 4.8% in the 4th quarter. Great Lakes Advisors LLC now owns 1,624 shares of the financial services provider's stock valued at $377,000 after acquiring an additional 75 shares in the last quarter. Institutional investors and hedge funds own 87.75% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on the stock. Keefe, Bruyette & Woods raised their price objective on shares of CME Group from $265.00 to $273.00 and gave the company a "market perform" rating in a research report on Thursday, April 24th. UBS Group upped their price objective on CME Group from $290.00 to $305.00 and gave the stock a "buy" rating in a report on Friday, April 25th. Morgan Stanley upped their price objective on CME Group from $301.00 to $304.00 and gave the stock an "overweight" rating in a report on Thursday, April 24th. Oppenheimer upped their price objective on CME Group from $282.00 to $300.00 and gave the stock an "outperform" rating in a report on Wednesday, June 4th. Finally, Royal Bank Of Canada reaffirmed a "sector perform" rating and issued a $269.00 target price on shares of CME Group in a research note on Thursday, April 3rd. Four investment analysts have rated the stock with a sell rating, eight have given a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average target price of $260.93.

Get Our Latest Research Report on CME Group

Insider Activity

In related news, Director Charles P. Carey sold 500 shares of the business's stock in a transaction on Tuesday, June 10th. The shares were sold at an average price of $265.35, for a total transaction of $132,675.00. Following the transaction, the director directly owned 4,900 shares in the company, valued at approximately $1,300,215. The trade was a 9.26% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, General Counsel Jonathan L. Marcus sold 390 shares of the business's stock in a transaction on Tuesday, May 20th. The stock was sold at an average price of $277.50, for a total transaction of $108,225.00. Following the transaction, the general counsel owned 6,708 shares in the company, valued at approximately $1,861,470. The trade was a 5.49% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 13,400 shares of company stock worth $3,680,610. Corporate insiders own 0.30% of the company's stock.

CME Group Trading Up 0.8%

CME Group stock traded up $2.17 during midday trading on Monday, hitting $277.25. 258,665 shares of the stock were exchanged, compared to its average volume of 2,173,594. The company has a fifty day simple moving average of $276.58 and a two-hundred day simple moving average of $259.51. CME Group Inc. has a 52 week low of $193.25 and a 52 week high of $290.79. The stock has a market capitalization of $99.91 billion, a PE ratio of 27.90, a P/E/G ratio of 4.45 and a beta of 0.44. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13.

CME Group (NASDAQ:CME - Get Free Report) last released its quarterly earnings data on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share for the quarter, topping the consensus estimate of $2.61 by $0.19. The business had revenue of $1.64 billion for the quarter, compared to analyst estimates of $1.56 billion. CME Group had a net margin of 57.71% and a return on equity of 14.03%. CME Group's quarterly revenue was up 10.4% compared to the same quarter last year. During the same quarter last year, the firm earned $2.50 EPS. Equities research analysts anticipate that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, June 25th. Shareholders of record on Monday, June 9th were issued a dividend of $1.25 per share. The ex-dividend date of this dividend was Monday, June 9th. This represents a $5.00 annualized dividend and a yield of 1.80%. CME Group's dividend payout ratio (DPR) is currently 50.30%.

CME Group Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Featured Articles

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Should You Invest $1,000 in CME Group Right Now?

Before you consider CME Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.

While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Watch Before Monday: Stocks to Load Up on Before Earnings
3 Hot Growth Stocks to Watch Right Now!
Don’t Miss These Top 3 Defense Stocks Set To Gain

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines